Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06950008

A Patient Navigation Intervention for the Improvement of Risk Management Among Women at High Risk of Breast Cancer

Feasibility Testing of a Patient Navigation Intervention to Improve Risk Management Among Women at High Risk of Breast Cancer

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
75 (estimated)
Sponsor
Ohio State University Comprehensive Cancer Center · Academic / Other
Sex
Female
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

This clinical trial studies whether a patient navigation (PN) intervention can be used to improve risk management among women at high risk of breast cancer. Women with a family history of breast cancer have a higher lifetime risk of developing it. Risk management can benefit women at high risk of breast cancer and can include surveillance routines, preventative surgeries, and medications that can dramatically lower the risk of breast cancer and allow early detection. Although risk management can benefit women at high risk of breast cancer, only a small amount actually use it. PN is a healthcare service that is designed to guide a patient through the healthcare system and reduce barriers to timely screening, follow-up, diagnosis, treatment, and supportive care. The PN intervention in this study is designed to help give women the information and support they need to make choices about their breast cancer risk that they feel good about, which may improve risk management.

Detailed description

PRIMARY OBJECTIVE: I. Test the feasibility of the PN intervention and of recruiting participants to a randomized controlled trial of the intervention. OUTLINE: Participants are randomized to 1 of 2 arms. ARM I: Participants receive links to informational websites on breast cancer risk and risk management options on study. Participants also receive phone calls from a single patient navigator and discuss breast cancer risk and risk-management options once a month for 8 months. Participants may choose to receive additional patient navigator phone calls as needed on study. ARM II: Participants receive links to informational websites on breast cancer risk and risk management options on study. After completion of study intervention, participants are followed for up to 1 month.

Conditions

Interventions

TypeNameDescription
OTHEREducational InterventionReceive links to informational websites
BEHAVIORALPatient NavigationReceive patient navigator phone calls
OTHERSurvey AdministrationAncillary studies
BEHAVIORALTelephone-Based InterventionReceive patient navigator phone calls

Timeline

Start date
2025-09-01
Primary completion
2027-01-31
Completion
2027-01-31
First posted
2025-04-29
Last updated
2026-04-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06950008. Inclusion in this directory is not an endorsement.